Trial Profile
Post Marketing Clinical Study of Aripiprazole in Patients With Schizophrenia - Effects on Glucose Metabolism.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- Sponsors Otsuka Pharmaceutical
- 13 Jul 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 13 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.